[HTML][HTML] Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc: ceramide …

SB Levery, M Momany, R Lindsey, MS Toledo… - FEBS letters, 2002 - Elsevier
SB Levery, M Momany, R Lindsey, MS Toledo, JA Shayman, M Fuller, K Brooks, RL Doong…
FEBS letters, 2002Elsevier
The opportunistic mycopathogen Aspergillus fumigatus expresses both glucosylceramide
and galactosylceramide (GlcCer and GalCer), but their functional significance in Aspergillus
species is unknown. We here identified and characterized a GlcCer from Aspergillus
nidulans, a non-pathogenic model fungus. Involvement of GlcCer in fungal development
was tested on both species using a family of compounds known to inhibit GlcCer synthase in
mammals. Two analogs, D-threo-1-phenyl-2-palmitoyl-3-pyrrolidinopropanol (P4) and D …
The opportunistic mycopathogen Aspergillus fumigatus expresses both glucosylceramide and galactosylceramide (GlcCer and GalCer), but their functional significance in Aspergillus species is unknown. We here identified and characterized a GlcCer from Aspergillus nidulans, a non-pathogenic model fungus. Involvement of GlcCer in fungal development was tested on both species using a family of compounds known to inhibit GlcCer synthase in mammals. Two analogs, D-threo-1-phenyl-2-palmitoyl-3-pyrrolidinopropanol (P4) and D-threo-3′,4′-ethylenedioxy-P4, strongly inhibited germination and hyphal growth. Neutral lipids from A. fumigatus cultured in the presence of these inhibitors displayed a significantly reduced GlcCer/GalCer ratio. These results suggest that synthesis of GlcCer is essential for normal development of A. fumigatus and A. nidulans.
Elsevier